Month: November 2011
-
Researchers from Université Laval affiliated CHUQ discover a new therapeutic target for Lou Gehrig’s disease
November 14, 2011. – A research team from Université Laval, led by Jean-Pierre Julien, has taken a new step in understanding the cellular mechanisms involved in Lou Gehrig’s disease, also known as amyotrophic lateral sclerosis (ALS). This disease is characterized by degeneration of neurons that control muscle activity.